TE-8105

· Immunwork, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TE-8105, covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate the Safety and Tolerability of TE-8105 in Overweight/Obese Participants Without Diabetes [Phase 1, Phase 2]

See pricing